The JPH3 gene Huntington Disease-like Type 2 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the JPH3 gene, which are associated with Huntington Disease-like 2 (HDL2). HDL2 is a rare neurodegenerative disorder that shares many clinical features with Huntington's disease, including movement disorders, psychiatric disturbances, and cognitive decline. The condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the JPH3 gene can lead to the disease.
This test is crucial for individuals with a family history of HDL2 or those exhibiting symptoms suggestive of Huntington's disease but who have tested negative for the more common HTT gene mutation associated with Huntington's. Early and accurate diagnosis through the JPH3 gene test can facilitate better management of the condition, allow for genetic counseling, and inform family planning decisions.
The test is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. By opting for this test, patients and their families can gain valuable insights into their genetic status and take proactive steps in managing their health.
The ARX gene, known for its pivotal role in brain development and function, has been linked to a range of neurological disorders, including Hydranencephaly with Abnormal Genitalia and Lissencephaly X-Linked 2. These conditions are characterized by severe brain malformations and, in some cases, abnormalities in genital development. Hydranencephaly involves the replacement of the brain's cerebral hemispheres with sacs filled with cerebrospinal fluid, while Lissencephaly X-Linked 2 is marked by a "smooth brain" due to abnormal neuronal migration, leading to intellectual disability and seizures.
To diagnose these conditions, genetic testing targeting the ARX gene can be instrumental. DNA Labs UAE offers a specialized genetic test for this purpose. The test aims to identify mutations in the ARX gene that are indicative of these disorders, providing crucial information for diagnosis, treatment planning, and genetic counseling. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to conduct such specialized genetic analysis. By opting for this test, individuals can gain valuable insights into their genetic makeup, empowering them with information that can guide medical and personal decision-making.
The "L1CAM Gene Hydrocephalus with Aqueductal Stenosis and Congenital Intestinal Pseudoobstruction Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the L1CAM gene. These mutations are linked to a spectrum of severe conditions including hydrocephalus, characterized by the accumulation of cerebrospinal fluid in the brain due to aqueductal stenosis (a narrowing of the brain's aqueduct of Sylvius), and congenital intestinal pseudo-obstruction, a severe disorder affecting the normal movements of the intestines. The test, priced at 4400 AED, is crucial for early diagnosis and management, guiding treatment plans and genetic counseling for affected families. It involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific genetic alterations in the L1CAM gene, providing insights into the risk and presence of these complex conditions.
The PRNP Gene Gerstmann-Straussler Disease Genetic Test is a specialized diagnostic procedure designed to detect mutations in the PRNP gene, which are associated with Gerstmann-Straussler-Scheinker (GSS) disease. GSS is a rare, inherited neurodegenerative disorder characterized by ataxia, dementia, and various neurological symptoms, resulting from the abnormal accumulation of prion proteins in the brain. The test involves analyzing the patient's DNA to identify specific genetic alterations in the PRNP gene that are linked to the development of GSS.
Conducted at DNA Labs UAE, this genetic test is crucial for individuals with a family history of GSS or those presenting symptoms suggestive of prion diseases. Early and accurate diagnosis through genetic testing can aid in the management of the disease, although there is currently no cure. Counseling may also be recommended to discuss the implications of the test results for the patient and their family.
The cost of the PRNP Gene Gerstmann-Straussler Disease Genetic Test at DNA Labs UAE is 4400 AED. This price may cover the genetic analysis, professional fees, and post-test counseling. It's important for patients to consult with their healthcare providers to understand the potential benefits, limitations, and risks associated with the test before proceeding.
The GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, aimed at detecting mutations in the GAN gene, which are responsible for Giant Axonal Neuropathy (GAN) Type 1. This rare, inherited neurological disorder is characterized by a progressive decline in nerve function, affecting both the central and peripheral nervous systems. Symptoms typically emerge in early childhood and can include muscle weakness, motor skill regression, and in severe cases, impairment of sensory functions.
The test is crucial for early diagnosis and management of the condition, offering insights into potential treatments and interventions that can improve quality of life. Conducted through a detailed analysis of the patient's DNA, it seeks to identify specific genetic alterations in the GAN gene that confirm the diagnosis of GAN Type 1.
The cost of the GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive genetic screening process, leveraging advanced technology and expertise to ensure accurate and reliable results. Given the complexity and rarity of the condition, this genetic test represents a critical step towards personalized care and management for affected individuals and their families.
The "ITPR1 Gene Gillespie Syndrome Genetic Test" is a specialized diagnostic procedure conducted to detect mutations in the ITPR1 gene, which are linked to Gillespie Syndrome, a rare genetic disorder. This syndrome is characterized by partial aniridia (a condition where the iris is partially absent), ataxia (lack of muscle coordination), and intellectual disability. The test is crucial for confirming the diagnosis, enabling early intervention, and providing targeted management to affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the ITPR1 gene to identify any genetic abnormalities that may be responsible for the syndrome. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately diagnose this rare condition. Through this test, families and healthcare providers can gain valuable insights into the genetic basis of Gillespie Syndrome, facilitating informed decisions about care and support for those affected.
The SLC2A1 gene is crucial for encoding the glucose transporter protein GLUT1, which facilitates the transport of glucose across the blood-brain barrier to fuel the brain. GLUT1 Deficiency Syndrome Type 1 is a rare genetic disorder that arises from mutations in the SLC2A1 gene, leading to inadequate glucose transport into the brain. This condition can result in a spectrum of neurological issues, including developmental delay, seizures, movement disorders, and speech difficulties.
To diagnose this condition, a genetic test targeting the SLC2A1 gene can be conducted. This test identifies mutations in the SLC2A1 gene that are responsible for GLUT1 Deficiency Syndrome Type 1. DNA Labs UAE offers this specialized genetic test, providing a crucial tool for diagnosing affected individuals. The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the SLC2A1 gene.
Early diagnosis through genetic testing is vital for managing GLUT1 Deficiency Syndrome Type 1, as it can guide treatment strategies, including dietary modifications like the ketogenic diet, which has been shown to improve symptoms in affected individuals.
The AMT Gene Glycine Encephalopathy Genetic Test is a specialized diagnostic procedure designed to detect mutations in the AMT gene, which are associated with Glycine Encephalopathy, also known as Nonketotic Hyperglycinemia (NKH). This condition is a rare genetic disorder characterized by an excess of glycine in the brain, leading to severe neurological symptoms such as intellectual disability, seizures, and hypotonia. Early detection through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, usually through a blood draw or buccal swab. The laboratory then examines the AMT gene for specific mutations known to cause Glycine Encephalopathy. This test is particularly important for families with a history of the condition or for newborns showing symptoms suggestive of NKH.
The cost of the AMT Gene Glycine Encephalopathy Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a definitive diagnosis cannot be overstated, as it opens the door to targeted treatments and interventions that can significantly improve outcomes for those affected by this challenging condition.
The GCSH Gene Glycine Encephalopathy Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the GCSH gene, which are associated with Glycine Encephalopathy, also known as Non-Ketotic Hyperglycinemia (NKH). This condition is a rare but severe metabolic disorder that affects the brain and nervous system, leading to a wide range of neurological symptoms. Early detection through genetic testing is crucial for managing the condition and providing appropriate treatment to improve the quality of life for affected individuals.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the GCSH Gene Glycine Encephalopathy Genetic Test is 4400 AED. This comprehensive test involves analyzing the patient's DNA to look for specific mutations in the GCSH gene that are known to cause Glycine Encephalopathy. By identifying these mutations, healthcare providers can confirm a diagnosis, understand the severity of the condition, and tailor treatment plans accordingly. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable test results, making it a trusted choice for genetic testing in the region.
The MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the MGAT2 gene. These mutations are responsible for a rare condition known as Congenital Disorder of Glycosylation Type IIa (CDG-IIa), which affects the body's ability to properly attach sugar molecules to proteins (glycosylation). This disorder can lead to a wide range of symptoms, including developmental delay, intellectual disabilities, and abnormalities in various organs.
The test is conducted through a comprehensive analysis of the patient's DNA, specifically targeting the MGAT2 gene to identify any genetic alterations. Given the complexity and precision of the testing process, the cost for this genetic test is set at 4400 AED. DNA Labs UAE utilizes advanced genomic technologies to ensure accurate and reliable results, providing essential information for the diagnosis, management, and potential treatment of this genetic condition. This test is crucial for families seeking answers to unexplained symptoms related to glycosylation disorders, offering a path towards better understanding and management of the condition.
